Viewing StudyNCT01573247



Ignite Creation Date: 2024-05-06 @ 12:25 AM
Last Modification Date: 2024-10-26 @ 10:49 AM
Study NCT ID: NCT01573247
Status: TERMINATED
Last Update Posted: 2016-03-25
First Post: 2012-03-28

Brief Title: Safety Study of AKN-028 in Patients With Acute Myelogenous Leukemia
Sponsor: Akinion Pharmaceuticals AB
Organization: Akinion Pharmaceuticals AB

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia
Keywords:
Name View
kinase inhibitor View
Acute myeloid leukemia View
Refractory Acute myeloid leukemia View
FLT3 inhibitor View